ESRP1 and pancreatic neoplasm: miR-23a increased alternative splicing of CD44v to CD44s and FGFR2 IIIb to IIIc via downregulation of ESRP1 expression by binding to its 3’ UTR, thereby promoting EMT and metastasis in pancreatic cancer [75].